How to price based upon the expected overhead of $70million Euro to launch?
Then, the goal should be gross sales of $100-110million Euro the first year?
Is this real? Yes, it’s rare disease. Realistically, how many patients suffer annually? How many are diagnosed and treated? How many have consistent access to a health care provider?
What’s the age group for the patients? This will dictate US insurance coverage.
We have more questions for on this topic, although we can give you a realistic goal to achieve if asked? We can also give you advice on exact pricing to turn a profit but not the patient support groups off.
Competition
You had great ideas of being first to market and then the other start-up beat you by one year?
Can you enter the market anyway? You drug needs to clearly show better efficacy…safer? maybe.
More effective than a higher priced competitor?
What about Medicaid and Medicare? It depends, you do not always need Medicaid contracts
Commercial, be ready to absorb the co-insurance cost per patient, it will make a difference for profit.
Contact us with more questions. We have been in this business for 35 years especially in Neuroscience.
Neurology Life Science Consulting
address goes here
info@pharmakonsult.com
+1234567890
